ASCORBIC ACID injection, for intravenous use
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2026-09-03
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-09-30 01:02:41
Label at a glance#
Label contents#
Full prescribing information#
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0370710216412 | GTIN-13: 0370710216412 EAN-13: 0370710216412 GTIN-12: 370710216412 UPC-A: 370710216412 GTIN storage (14 digits): 00370710216412 | db495704-ebb9-4090-b28a-b30b73e10ffa-03.jpg |
Products#
Every source-derived product name is available through these pages.
- Ascorbic acid
- EDETATE DISODIUM
- SODIUM BICARBONATE
- SODIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1943 | 70771-1943-8, 70771-1943-9 |
| 70771-1944 | 70771-1944-8, 70771-1944-9 |
| 70771-1945 | 70771-1945-8, 70771-1945-9 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220873-001 | ASCORBIC ACID | ASCORBIC ACID | 2,500MG/5ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | |
| A220873-002 | ASCORBIC ACID | ASCORBIC ACID | 5,000MG/10ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | |
| A220873-003 | ASCORBIC ACID | ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-08-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220873-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220873-001 | ASCORBIC ACID | 2,500MG/5ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220873-002 | ASCORBIC ACID | 5,000MG/10ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220873-003 | ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-08-20 | 84e616aacf4f… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220873-003 | AP | 1 | 84e616aacf4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | Ascorbic Acid ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | Ascorbic Acid ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


